GG
GILD icon

Gleason Group’s Gilead Sciences GILD Stock Holding History

Gleason Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
9,418
+145
+2% +$19.1K 0.1% 44
2026
Q1 		$1.29M Buy
9,273
+56
+0.6% +$7.84K 0.13% 38
2025
Q4 		$1.13M Buy
9,217
+58
+0.6% +$7.05K 0.11% 42
2025
Q3 		$1.02M Buy
9,159
+64
+0.7% +$7.28K 0.1% 41
2025
Q2 		$1.01M Buy
9,095
+67
+0.7% +$7.13K 0.11% 40
2025
Q1 		$1.01M Buy
9,028
+64
+0.7% +$6.6K 0.18% 38
2024
Q4 		$828K Buy
8,964
+72
+0.8% +$6.48K 0.15% 41
2024
Q3 		$745K Buy
8,892
+5
+0.1% +$382 0.14% 43
2024
Q2 		$610K Buy
8,887
+174
+2% +$11.6K 0.12% 46
2024
Q1 		$638K Buy
8,713
+91
+1% +$7K 0.13% 46
2023
Q4 		$698K Buy
8,622
+80
+0.9% +$6.22K 0.16% 45
2023
Q3 		$640K Buy
8,542
+84
+1% +$6.46K 0.17% 42
2023
Q2 		$652K Buy
8,458
+82
+1% +$6.54K 0.17% 45
2023
Q1 		$695K Buy
8,376
+77
+0.9% +$6.38K 0.2% 45
2022
Q4 		$712K Buy
8,299
+72
+0.9% +$5.7K 0.22% 42
2022
Q3 		$508K Buy
8,227
+93
+1% +$5.86K 0.18% 43
2022
Q2 		$503K Buy
8,134
+94
+1% +$5.82K 0.17% 45
2022
Q1 		$478K Buy
8,040
+97
+1% +$6.2K 0.14% 46
2021
Q4 		$577K Buy
7,943
+76
+1% +$5.24K 0.19% 43
2021
Q3 		$550K Buy
7,867
+79
+1% +$5.55K 0.2% 45
2021
Q2 		$536K Buy
7,788
+80
+1% +$5.34K 0.19% 45
2021
Q1 		$498K Buy
7,708
+2,083
+37% +$134K 0.2% 44
2020
Q4 		$328K Buy
5,625
+66
+1% +$3.98K 0.16% 50
2020
Q3 		$351K Buy
+5,559
New +$385K 0.2% 49

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gleason Group's GILD Position: Q2 2026 in Review

Gleason Group increased its Gilead Sciences (GILD) stake by 1.6% in Q2 2026, buying an estimated $19.1K and bringing the position to 9,418 shares worth $1.19M. The position accounts for 0.1% of the portfolio, ranked #44.

Gleason Group first reported a position in GILD in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.29M in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Gleason Group held 9,418 shares of Gilead Sciences worth $1.19M as of Q2 2026.
  • Gleason Group bought 145 Gilead Sciences shares in Q2 2026, an estimated $19.1K.
  • Gilead Sciences made up 0.1% of Gleason Group's portfolio in Q2 2026, its #44 holding.
  • Gleason Group first reported a position in Gilead Sciences in Q3 2020 and has held it in 24 quarters since.
  • Gleason Group's Gilead Sciences position peaked at $1.29M in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.